Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Am J Surg Pathol. 2018 Oct;42(10):1370–1383. doi: 10.1097/PAS.0000000000001119

Table 2.

Immunohistochemical and Molecular Profile of Uterine PEComas

Case # HMB-45 Melan-A MiTF Cathepsin K Desmin h-caldesmon SMA TFE3 RAD51B
1 4+ H 3+ S 2+ H 4+ S 0 1+ 0 - -
2 PPR PPR NP NP 0 NP PPR NP NP
3 3+ S 1+ S 1+ W 4+ S 1+ S 2+ H 2+ S - -
4 4+ S 4+ H 2+ W 4+ S 1+ W 3+ H PPR - -
5 3+ H PPR NP NP NP NP 4+ S - -
6 4+ S 1+ W 0 4+ S 0 1+ S 2+ S - -
7 3+ S 0 0 4+ S 4+ S 4+ S 3+ S Failed Failed
8 4+ S 3+ H 1+ W 4+ S 1+ S 1+ W 1+ H - -
9 4+ S 4+ S 0 4+ S 1+ H 2+ S 4+ S - -
10 3+ S 1+ W 1+ W 4+ S 3+ H 1+ S 1+ S - -
11 4+ S (Ep)
0 (Sp)
4+ S (Ep)
0 (Sp)
0 (Ep/Sp) 4+ S (Ep)
0 (Sp)
0 (Ep)
4+ (Sp)
0 (Ep)
4+ (Sp)
0 (Ep)
4+ (Sp)
- -
12 2+ S 1+ S 2+ W 4+ S 2+ S 0 0 - RAD51B-OPHN1
13 4+ S 2+ H 1+ W 4+ H 1+ S 0 NP - -
14 4+ S 0 0 4+ S 0 0 4+ S PSF-TFE3 -
15 4+ S 3+ H 4+ S 4+ S 3+ S 0 2+ H - -
16 4+ S 0 1+ W 4+ S 4+ S 0 4+ S - -
17 4+ S 0 1+ W 4+ S 2+ S 0 PPR - -
18 4+ S 1+ H 3+ H 4+ S 4+ S 4+ S 4+ S - -
19 4+ S 4+ H 4+ W 4+ S 3+ S 2+ S 4+ H - -
20 1+ H 1+ S 3+ W 4+ S 2+ S 4+ S 4+ S - -
21 4+ S 4+ S 4+ S 2+ W 0 0 0 - -
22 2+ S 2+ S 0 2+ H 4+ S 4+ S 3+ S - -
23 4+ S 1+ S 3+ W 4+ S 4+ S 4+ S 4+ S - -
24 2+ S 1+ H 4+ S 3+ S 4+ S 4+ S 4+ S - -
25 4+ H 0 4+ H 4+ S 4+ S 4+ S 4+ S - -
26 4+ S 0 3+ H 4+ S 4+ S 4+ S 4+ S - -
27 4+ S 0 0 4+ S 4+ S 4+ S 4+ S - -
28 4+ S 1+ W 2+ W 4+ H 0 4+ S 4+ S - -
29 4+ H 1+ W 3+ H 4+ S 4+ S 2+ S 4+ S - -
30 4+ S 0 4+ S 4+ S 4+ S 2+ S 4+ S - -
31 4+ S 4+ S 2+ H 4+ S 0 1+ H 2+ S - -
32 1+ S 1+ S 0 4+ S 4+ S 4+ S 4+ S - -

<1% (0), 1–5% (1+), 6–25% (2+), 26–50% (3+), >50% (4+), strong (S), heterogeneous (H), weak (W)

SMA=smooth muscle actin; PPR=positive per report; NP=not performed; Ep=epithelioid component; Sp=spindled component